3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
28
Phase 1
17
Phase 1/2
13
Phase NA
11
Phase 3
9
Phase 4
3
Phase EARLY_PHASE1
2
Phase 2/3
2
Status
Completed
8
Recruiting
3
Unknown
2
Terminated
1
Not yet recruiting
1
Sponsor Class
OTHER
2
INDUSTRY
1
Study Type
Interventional
3
Sponsor
Cancer Type
NET
3
Endocrine
3
Gastrointestinal
2
Genitourinary
1
Breast
1
Conditions
Breast Neoplasms
33
Neoplasms
16
Prostatic Neoplasms
15
Lung Neoplasms
11
Carcinoma, Hepatocellular
11
Multiple Myeloma
9
Colorectal Neoplasms
9
Carcinoma, Non-Small-Cell Lung
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Papillomavirus Infections
6
Pain, Postoperative
6
Neoplasm Metastasis
6
Liver Neoplasms
6
Leukemia, Myeloid, Acute
6
Stomach Neoplasms
5
Recurrence
5
Lymphoma, Non-Hodgkin
4
Kidney Neoplasms
4
Heart Failure
4
Glioma
4
Febrile Neutropenia
4
Carcinoma, Renal Cell
4
Brain Neoplasms
4
Warts
3
Vomiting
3
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Skin Neoplasms
3
Rectal Neoplasms
3
Pituitary Neoplasms
3
Interventions
surufatinib
1
lanreotide
1
gadoteridol
1
gadoterate meglumine
1
gadolinium ethoxybenzyl DTPA
1
gadodiamide
1
gadobutrol
1
gadobenic acid
1
Somatostatin
1
Octreotide
1
Neuropsychological Tests
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 4
×
Recruiting
×
Neuroendocrine Tumors
×
Clear all
NCT04373564
2026-01-22
ODYSSEY
Guerbet
Phase 4
Recruiting
2,076 enrolled
NCT07272512
2025-12-19
ZSPAC-17
Shanghai Zhongshan Hospital
Phase 4
Recruiting
350 enrolled
NCT05701241
2024-06-14
SAUNA
University Hospital, Antwerp
Phase 4
Recruiting
270 enrolled